PCDE-EASD Study Group

PCDE prioritised research among other areas in the past year.

The  study group increased its membership (now 32 members from various European countries) to include several new primary care researchers to help the existing team. The guiding principles in this arena are

  • To encourage high quality research into treatment outcomes and evaluations of new treatment options diabetes in primary care.
  • To build a European network of primary care researchers, with wide interests on diabetes
  • To share research findings.

Cognisant of this, the group prioritised diabetes and other chronic medical problems that complicate the management of the condition in patients. The group has carried out and published research work on prevention of kidney deterioration in diabetes through the use of SGLT2-Is and also the management of diabetes in people with severe mental illness. Additionally, in collaboration with Adelphi Diabetes Disease Specific Programme, the group completed an abstract and presented it as a poster at the IDF conference in 2017 in Abu Dhabi on the evaluation of the trends in therapeutic inertia among 3 groups of interest in a primary care physician (PCP) and diabetes specialist setting over the past 4 years.

Following the successful completion of these projects, the group has this year expanded its research horizon by working in different European countries on a wide variety of topics. Some of the topic areas we are currently conducting research include de-intensifications of medications in the elderly population, the evaluation and validation of decision making software to assist clinicians on the choice of anti-diabetes drugs, epidemiological work on the trends in medication adherence in diabetes and multi-morbidity in diabetes. Research output from these topic areas will be presented and/or published in the next couple of years.

PCDE Position statement; published: https://www.ncbi.nlm.nih.gov/pubmed/30792156